X-ray powder diffraction patterns for certain fluoroquinolone antibiotic drugs

Acta Pharmaceutica

Volumn 53, Issue 4, 2003, Pages 295-303

  Thangadurai, Subbiah ^a   Shukla, Sudhir Kumar ^b   Srivastava, Asim Kumar ^b   Anjaneyulu, Yerramilli ^c  

^a Department of Geology and Mining ^*  (India)

^b BPR and D   (India)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Antibiotic drugs; Fluoroquinolones; Identification; Powder; X ray diffraction

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ARTICLE; CRYSTAL STRUCTURE; DRUG IDENTIFICATION; X RAY POWDER DIFFRACTION;

EID: 0346458896     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. L. A. Mitscher, P. V. Devasthale and R. M. Zavod, The 4-Quinolones: Antibacterial Agents In Vitro (Ed. G. C. Crumplin), Springer Verlag, Berlin 1990, pp. 115-135.
2. nd ed., SSCI, West Lafayette 1999, pp. 64-87.
3. R. Jenkins and R. L. Snyder, Indroduction to X-Ray Powder Diffractometry, Vol. 138, Wiley - Interscience, New York 1996, pp. 355-378.
4. A. P. Queredo, H. N. de Armas and L. X. Marill, X-ray powder diffraction data for 2,4-dichlo-ro-5-nitro benzoic acid, Powder Diffr. J. 13 (1998) 20-23.
5. Y. Che, J. Zheng, J. Hao and L. Chu, X-ray powder diffraction analysis of organic adduct m-nitrobenzoic acid for non linear optics diethanolamine, Powder Diffr. J. 16 (2001) 165-166.
6. S. Hayashi and H. Toraya, Quantitative phase analysis of natural products using whole powder pattern decomposition, Powder Diffr. J. 15 (2000) 86-90.
7. J. E. Kountourellis, C. K. Markopoulou, F. A. Underwood and B. Chapman, X-ray powder diffraction data for nine analgesics, Talanta 38 (1991) 233-235.
8. 2, Powder Diffr. J. 15 (2000) 108-111.
9. 4, Powder Diffr. J. 15 (2000) 112-115.
10. N. V. Phadnis, R. K. Cavatur and R. Suryanarayanan, Identification of drugs in pharmaceutical dosage forms by X-ray powder diffractometry, J. Pharm. Biomed. Anal. 15 (1997) 929-943.
11. 2, Powder Diffr. J. 14 (1999) 142-144.
12. P. J. Thatcher and G. P. Briner, The application of X-ray powder diffraction to forensic science, Powder Diffr. J. 4 (1986) 320-324.
13. C. J. Curry, D. F. Rendle and A. Rogers, Pigment analysis in the forensic examination of paints. Part 1: pigment analysis by X-ray powder diffraction, J. Forensic Sci. Soc. 22 (1982) 173-174.
14. th ed., The Pharmaceutical Press, London 1993, pp. 145-202.
15. The United States Pharmacopeia XXIV, NF XXI, US Pharmacopeial Convention, Rockville 2001, pp. 1535-1542.
16. British Pharmacopoeia, Her Majesty's Stationary Office, London 1999, Vol. 1, pp. 368.
17. Indian Pharmacopoeia, Addendum 2000, The Controller of Publication, Ministry of Health and Family Welfare, Government of India, New Delhi 1996, pp. 840-868.
18. I. Turel, I. Leban, M. Zuancic, P. Bukovec and K. Gruber, An adduct of magnesium sulfate with a member of the quinolone family: Ciprofloxacin, Acta Cryst. Sec. C. 52 (1996) 2443-2445.
19. A. J. Florence, A. R. Kennedy, N. Shankland, E. Wright and A. Al-Rubayi, Norfloxacin dihydrate, Acta Cryst. Sec. C. 56 (2000) 1372-1373.
20. N. C. Baenziger, The structure of silver pefloxacin, an antibiotic related to nalidixic acid, Acta Cryst. Sec. C. 42 (1986) 1505-1508.
21. M. C. Morris, H. F. McMurdie and E. H. Evans, Standard X-Ray Diffraction Powder Patterns. Section 16: Data for 86 Substances (Monographs/US National Bureau of Standards, 25), National Technical Information Service, Springfield 1979, pp. 1-5.